MindWalk Holdings Corp. Files 6-K with Pro Forma Financials
Ticker: HYFT · Form: 6-K · Filed: Oct 14, 2025 · CIK: 1715925
Sentiment: neutral
Topics: financial-reporting, pro-forma, sec-filing
TL;DR
MindWalk Holdings Corp. (MWC) dropped pro forma financials in a 6-K filing, check Exhibit 99.1 for the latest numbers.
AI Summary
MindWalk Holdings Corp. (formerly ImmunoPrecise Antibodies Ltd.) filed a Form 6-K on October 14, 2025, reporting for the month of October 2025. The filing includes Unaudited Pro Forma Condensed Consolidated Financial Information as Exhibit 99.1, which is incorporated by reference into several of the company's registration statements.
Why It Matters
This filing provides updated pro forma financial information, which can offer insights into the company's financial position and potential future performance under specific scenarios.
Risk Assessment
Risk Level: low — The filing is a routine report of financial information and does not contain significant new operational or strategic disclosures that would immediately alter risk perception.
Key Numbers
- 99.1 — Exhibit Number (Contains Unaudited Pro Forma Condensed Consolidated Financial Information)
Key Players & Entities
- MindWalk Holdings Corp. (company) — Filer of the report
- ImmunoPrecise Antibodies Ltd. (company) — Former name of MindWalk Holdings Corp.
- 0001715925 (company) — Central Index Key for MindWalk Holdings Corp.
- 2834 (company) — Standard Industrial Classification for Pharmaceutical Preparations
- 001-39530 (company) — Commission File Number for MindWalk Holdings Corp.
- 333-256730 (company) — Registration Statement File Number (Form S-8)
- 333-273197 (company) — Registration Statement File Number (Form F-3)
- 333-281312 (company) — Registration Statement File Number (Form F-3)
- October 14, 2025 (date) — Filing date of the report
- October 2025 (date) — Reporting period
FAQ
What specific period does the Unaudited Pro Forma Condensed Consolidated Financial Information cover?
The filing is for the month of October 2025, and the pro forma information is presented as of April 30, 2025, as indicated by 'pro_forma_april_30_2025.htm'.
What is the primary purpose of this Form 6-K filing?
The primary purpose is to report the Unaudited Pro Forma Condensed Consolidated Financial Information as required for foreign private issuers.
Which registration statements incorporate this filing by reference?
Exhibit 99.1 is incorporated by reference into Registration Statement on Form S-8 (File No. 333-256730) and Registration Statements on Form F-3 (File Nos. 333-273197 and 333-281312).
What was MindWalk Holdings Corp.'s former name?
MindWalk Holdings Corp.'s former name was ImmunoPrecise Antibodies Ltd., with a date of name change on August 30, 2017.
Where is MindWalk Holdings Corp. headquartered?
The company's principal executive office is located at Industrious, 823 Congress Ave, Suite 300, Austin, Texas 78701.
Filing Stats: 182 words · 1 min read · ~1 pages · Grade level 10.5 · Accepted 2025-10-10 18:01:03
Filing Documents
- pro_forma_april_30_2025.htm (6-K) — 26KB
- hyft-ex99_1.htm (EX-99.1) — 685KB
- 0001193125-25-237260.txt ( ) — 713KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. MINDWALK HOLDINGS CORP. Date: October 10, 2025 By: /s/ Jennifer Bath Name: Jennifer Bath Title: President and Chief Executive Officer